Geron Corp (GERN)

With the first embryonic stem cell therapy in FDA human trials, things are looking fantastic for Geron. If you're looking for financials I'm the wrong guy, but following the news with their trial they've already weathered some sketchy news (micro-cysts) but things are back on track. As more good news gets released I expect large surges in the stock price.

Pullback Likely on Relatively Weak Stock

GERN has a too high valuation compared to its sales potential: its current sales are quasi nil. So it is one of the most loss making companies.

Feel the burn!

Cake Dex test run

Geron is a well managed, dedicated, and supurbly staffed company whose integrity is confirmed by their diligence to thoroughness and transparency to the stockholders. They have made exceptional progress in each and every one of their target categories of research, in the process, reporting and meeting obstacles head-on. Contrary to the negative press regarding the FDA's review of Geron's spinal cord injury tests on rats before permitting them to proceed with tests on humans, it is in fact not a delay as such, but rather part of the process to understand and overcome in progress experimental developments of concern.

No other biotech firm doing similar research has achieved anything close to the level of promise that Geron has achieved, yet the stock of some of those other biotech companies is priced in the $60's.

At the present price of $6.50 or so per share, Geron stock is the best buy out there. I strongly believe Geron is on the verge of several major advances and in the area of human spinal cord injury stem cell repair, a major break-through will be achieved by June of 2010. Until investors see the light, Geron will underpereform.

No thanks.

Can you day Obama ? GERN is where you want to be.

Fast money's lottery ticket drug play

I dunno... what goes up must come down etc... just no trust in stocks of little story stocks... even tho this is a very interesting story...

Sector will get a nice boost once the health bill get passed

very poor performance compared to it's peers

Fda approval and government change on stem cell therapy

Ive read every artical that has come out over thirteen years. Im cofident they will succeed with there Ebroyonic S C Treatment for the spin

hot stock and becoming a good chose for those that believe in it, it will work if given a chance.

they will work miracles

Geron can double every year for the next five years, as its cancer and stem cell treatments go from early clinical testing to mature products.

Another stem pick

Since the president signed the stem cell reserch bill, and since Gern is already a cheap stock, why won't it go up? It should go up by a lot in a year, so I would recommend buying an option on it.